Latest filing published 25 Mar 2022 for Jacobio Pharmaceuticals Group Co., Ltd. - B.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -52.8%Entry HK$12.22 · Close at T+365 HK$5.77
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Hu Shaojing: trading record in brief
Hu Shaojing is a declared insider of Jacobio Pharmaceuticals Group Co., Ltd. - B, with filings sourced from HKEX. We count 4 filings; the first trade dates from 18 January 2021 and the latest from 22 March 2022.
On the open market, the record shows 1 purchase worth €180k and 2 sales worth €13.7M. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2022 alone, the filings show 1 purchase and 1 sale.
Most recently, on 25 March 2022, the filings show an open-market sale in Jacobio Pharmaceuticals Group Co., Ltd. - B. The latest purchase dates back some time: it was published 1,754 days ago, on 20 January 2022. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Hu Shaojing
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 229,960,475 sharesShareXHKGHKEX:DA20220325E00345
- 127,500 shares@ HK$12.5171.3% of flowShareXHKGHKEX:DA20220120E00231Canonical exit: 17 Apr 2022 (T+90)
- 5,976,000 shares@ HK$21.0298.7% of flowShareXHKGHKEX:DA20210721E00303
- 277,098,975 sharesShareXHKGHKEX:DA20210119E00074
4 of 4 declarations